AI Uses Ape DNA to Predict Genetic Disease Risks in Humans

Date:

A new study by an international group of researchers utilizes a novel AI algorithm, PrimateAI-3D, to analyze data from primate DNA and predict potential genetic risks for humans. The scientists sequenced over 800 individual samples from 233 primate species to train the algorithm to recognize benign genetic variants and mutations that could cause diseases. The algorithm achieved impressive results while being able to avoid any genetic bias stemming from white European ancestry. In addition to assisting with health research, the study’s findings can help conserve the populations of other primates. Combining human and non-human primate data can help prioritize the variants that pose the most risk to humans.

The company Illumina collaborated on this research and employed Kyle Farh as co-author. Farh is the Vice President of Artificial Intelligence at Illumina.

The PrimateAI-3D algorithm uses deep-learning language architectures that are similar to those employed with ChatGPT. However, the PrimateAI-3D algorithms model genomic sequences instead of linguistic sequences.

See also  Microsoft's ChatGPT Expected to Cause Job Losses Beyond Expectations

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.